NCT06552559
- Conditions
- B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, CNS Metastases
- Locations
-
- Samsung Cancer Research Institute Seoul, South Korea
- Samsung Medical Center Seoul, South Korea
Clinical trial condition
B-cell Lymphoma Recurrent
Explore clinical trials studying B-cell Lymphoma Recurrent. Study availability and eligibility vary by location and protocol.
11 public trials
4 recruiting studies
B-cell Lymphoma Recurrent trial results
NCT06378190
- Conditions
- B-cell Lymphoma Recurrent, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Hospital Clínic Barcelona, Spain
- Institut Català d'Oncologia Hospital L'Hospitalet de Llobregat, Barcelona, Spain
- Fundación Jiménez Díaz Hospital Madrid, Spain
- Virgen de la Arrixaca University Hospital El Palmar, Mur, Spain
NCT05705570
- Conditions
- Acute Lymphoblastic Leukemia Refractory, Acute Lymphoblastic Leukemia, in Relapse, B-cell Lymphoma Recurrent, +14 more
- Locations
-
- Hospital Israelita Albert Einstein São Paulo, Brazil
NCT06445803
- Conditions
- Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia, in Relapse, B-cell Lymphoma Recurrent, +12 more
- Locations
-
- The First Affiliated Hospital of Nanchang University; Nanchang, Jiangxi, China
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma
NCT05909098
- Conditions
- B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, NK Cell
- Locations
-
- EC of Xiangyang No.1 People's Hospital Hubei University of Medicine Hubei, Xiangyang, China
Completed
MB-CART20.1 Lymphoma
NCT03664635
- Conditions
- B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, Disease Attributes, +15 more
- Locations
-
- University Hospital of Cologne - Clinic for Internal Medicine I Cologne, Germany
- Universitätsklikum Leipzig, AöR Leipzig, Germany
NCT05130489
- Conditions
- B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, +30 more
- Locations
-
- University College London Hospitals London, United Kingdom
NCT02843061
- Conditions
- B-cell Lymphoma Recurrent
- Locations
-
- Cancer Institute in Fuda cancer hospital Guangzhou, Guangdong, China
Active, Not Recruiting
MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)
NCT03853616
- Conditions
- Acute Lymphoblastic Leukemia Recurrent, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, +2 more
- Locations
-
- Charité - University clinic, pediatric clinic with focus on oncology and hematology Berlin, Germany
- Universitätsklinikum Erlangen Erlangen, Germany
- University medicine Goettingen, Clinic of hematology and medical oncology Göttingen, Germany
- Children's Hospital of Dr. von Hauner by Ludwig-Maximilian University Munich, Germany
Active, Not Recruiting
Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
NCT04531046
- Conditions
- B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory
- Locations
-
- CH Liège Liège, Belgium
- CHU de Bordeaux - Hôpital Haut Lévêque Bordeaux, France
- CHU Clermont Ferrand - Hôpital Estaing Clermont-Ferrand, France
- APHP - Hôpital Henri Mondor Créteil, France